Domains targeting keyword tumor registry software
Keyword tumor registry software was used in the provided list of websites.
Number of websites/domains displayed: 5
Results found: 5
Similar searches:
Websites discovered:
NAVIFY™ Tumor Board solution - Roche Diagnostics Information Solutionshttp://pageoverview.com/website-report/navify.com
A software solution for managing tumor boards and aligning oncology care teams on treatment decisions, hosted on a secure, compliant cloud infrastructure.
- Expected expiration: March 29th in 2019
- Creation date: March 29th in 2007
- Renew date: January 29th in 2018
- Google Analytics: 104934542-1
Brandon's Bloghttp://pageoverview.com/website-report/foszor.com
Husband, father, Android fiend, avid gamer and software developer... recently diagnosed with brain cancer but isn't giving up up on life!
- Expected expiration: June 25th in 2018
- Creation date: June 25th in 2003
- Renew date: June 25th in 2017
- Google Analytics: 5641537-8
Electronic Registry Systemshttp://pageoverview.com/website-report/ers-can.com
Electronic Registry Systems,Inc.(ERS) is the leader in cancer/tumor registry software. ERS allows cancer registrar's to record cancer information such as cancer stage, cancer treatment, and cancer diagnosis.
- Expected expiration: January 14th in 2019
- Creation date: January 15th in 1997
- Renew date: November 15th in 2016
- Google Analytics: 8848536-1
Brainlab—Medical Software and Hardware Innovatorshttp://pageoverview.com/website-report/brainlab.com
Dedicated to multi-modality treatment of benign skull base tumors, Adaptive Hybrid Surgery helps to balance surgical risk with radiosurgical toxicity.
- Expected expiration: December 20th in 2020
- Creation date: December 21st in 1995
- Renew date: February 7th in 2017
MiLaboratory.comhttp://pageoverview.com/website-report/milaboratory.com
MiLaboratory LLC develops software solutions for the deep error-free profiling of immune receptor repertoires (RepSeq) using high throughput sequencing (HTS, NGS), useful for bioinformatics - in studies of autoimmunity, vaccination, immunotherapy, hypersensitivity, checkpoint inhibitors (monoclonal antibodies), tumor infiltrating lymphocytes, T cell therapy, minimal residual disease, and adaptive immunity aging.
- Expected expiration: April 28th in 2018
- Creation date: April 28th in 2012
- Renew date: March 26th in 2017
- Google Analytics: 31409112-1